Clinical Trials · NCT02735031
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Radboud University Medical Center
- Enrollment
- 10
- Start date
- Feb 2017
- Locations
- 1 site, Netherlands
- Primary endpoint
- Symptom score in response to insulin-induced hypoglycaemia